Adam Simpson's Insider Trades & SAST Disclosures
Adam Simpson's most recent trade in Icosavax Inc was a trade of 15,000 Common Stock done at an average price of $15.3 . Disclosure was reported to the exchange on Jan. 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adam Simpson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.29 per share. | 30 Jan 2024 | 15,000 | 358,657 | - | 15.3 | 229,386 | Common Stock |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 30 Jan 2024 | 15,000 | 373,657 | - | 1.0 | 15,600 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2024 | 15,000 | 191,449 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2024 | 6,532 | 525,044 | - | 0 | Common Stock | |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 93,227 | 206,449 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 22 Jan 2024 | 93,227 | 358,657 | - | 1.0 | 96,956 | Common Stock |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 22 Jan 2024 | 4,789 | 265,430 | - | 0.8 | 4,023 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 4,789 | 0 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 15,000 | 299,676 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 02 Jan 2024 | 15,000 | 275,641 | - | 1.0 | 15,600 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 02 Jan 2024 | 15,000 | 260,641 | - | 15.7 | 235,088 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 102,574 | 314,676 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 20 Dec 2023 | 102,574 | 287,298 | - | 1.0 | 106,677 | Common Stock |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.46 per share. | 20 Dec 2023 | 62,205 | 184,724 | - | 15.5 | 961,509 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.44 per share. | 20 Dec 2023 | 50,000 | 300,641 | - | 15.4 | 772,220 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.47 per share. | 20 Dec 2023 | 40,000 | 327,298 | - | 2.5 | 98,800 | Common Stock |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.43 per share. | 20 Dec 2023 | 40,000 | 260,641 | - | 15.4 | 617,060 | Common Stock |
| Icosavax Inc | Simpson Adam | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 40,000 | 237,146 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 20 Dec 2023 | 23,343 | 350,641 | - | 0.8 | 19,608 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 23,343 | 4,789 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 01 Aug 2023 | 3,000 | 246,930 | - | 0.8 | 2,520 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 3,000 | 28,132 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.86 per share. | 31 Jul 2023 | 11,788 | 243,930 | - | 8.9 | 104,459 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 15 Feb 2023 | 10,677 | 255,718 | - | 1.0 | 11,104 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 10,677 | 417,250 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.69 per share. | 13 Feb 2023 | 7,506 | 245,041 | - | 10.7 | 80,259 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 25 Jan 2023 | 10,678 | 252,547 | - | 1.0 | 11,105 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 10,678 | 427,927 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 25 Jan 2023 | 2,395 | 241,869 | - | 0.8 | 2,012 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 2,395 | 31,132 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 277,146 | 277,146 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 29 Jul 2022 | 7,017 | 293,772 | - | 6.6 | 46,575 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.11 per share. | 29 Jul 2022 | 2,456 | 300,789 | - | 7.1 | 17,456 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 29 Jul 2022 | 1,904 | 291,869 | - | 6.7 | 12,764 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 7,185 | 47,896 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 01 Jul 2022 | 7,185 | 303,245 | - | 0.8 | 6,035 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2022 | 4,789 | 55,081 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 28 Mar 2022 | 4,789 | 220,482 | - | 0.8 | 4,023 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 317,866 | 317,866 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 75,578 | 291,271 | - | 0 | Common Stock | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jan 2022 | 125,000 | 531,576 | - | 0 | Common Stock | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jan 2022 | 125,000 | 129,032 | - | 0 | Common Stock | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jan 2022 | 125,000 | 129,032 | - | 0 | Common Stock | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jan 2022 | 125,000 | 656,576 | - | 0 | Common Stock | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2022 | 73,929 | 438,605 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 26 Jan 2022 | 73,929 | 215,693 | - | 1.0 | 76,886 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2022 | 16,764 | 59,870 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 26 Jan 2022 | 16,764 | 141,764 | - | 0.8 | 14,082 | Common Stock |
| Icosavax Inc | Adam Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 15.00 per share. | 30 Jul 2021 | 125,000 | 125,000 | - | 15 | 1,875,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges